Mycotoxins can be found in various environments, including homes and workplaces. Mycotoxins are substances produced by certain fungi or molds. People may be exposed to these substances, which could potentially affect their energy levels, cognitive function, and overall well-being. Symptoms can vary and may resemble other conditions, making mycotoxin exposure challenging to identify.
There is a mycotoxin screening available for individuals suspected of having mycotoxin-related health concerns. The Total Mycotoxins Panel by RealTime Laboratories can provide insights into mycotoxin exposure levels, which may help in developing strategies to manage exposure and support overall health.
[signup]
What is the Total Mycotoxin Panel by RealTime Laboratories?
The Total Mycotoxin Panel by RealTime Laboratories assesses for 16 different mycotoxins that may impact health. This lab's doctors and scientists have researched these mycotoxins to identify significant markers for assessment. The panel is completed through a urine sample, which is a non-invasive and stable method.
This test detects common mycotoxin groups that may affect health, including Aflatoxins, Ochratoxins, Macrocyclic, and Trichothecenes. The testing method used is ELISA, which is sensitive to mycotoxin antibodies. Detection levels are displayed as parts-per-billion (ppb), following standards by the FDA, WHO, CDC, and the food industry. The results indicate the presence and levels of each mycotoxin tested.
Which Patients Are the Total Mycotoxin Panel Best Used For?
Mycotoxin exposure may be associated with various health effects. When considering this test, it's important to evaluate potential chronic exposure, as these substances can be present in living or working environments. A thorough intake may be needed for individuals with symptoms that could be related to mycotoxin exposure, such as unexplained immune issues, fatigue, sinus problems, neuropathy, asthma, cognitive issues, chemical sensitivities, or mood changes. The intake should consider environmental factors, including any history of water damage or mold presence.
Individuals should also be asked about any mold odors in their environments, as this can indicate mold issues. A family history of allergies may increase susceptibility to mold reactions and should be considered. Conditions potentially related to mold exposure include lung issues, neurotoxicity, changes in kidney or lung function, immune suppression, mood imbalances, anemia, digestive issues, skin disruptions, and other health concerns.
What Does the Total Mycotoxin Panel Measure?
The Total Mycotoxin Panel measures 16 common mycotoxins that may impact health, including Aflatoxins, Ochratoxins, Macrocyclic Trichothecenes, and Gliotoxins. It also assesses for black mold caused by Stachybotrys.
This test evaluates Aflatoxins, which can be found in food or environments and are known to affect liver, kidney, and gut health. Ochratoxins are measured due to their potential impact on kidney health. Macrocyclic Trichothecenes can be present in grains, buildings, and HVAC systems, potentially affecting various body systems. Gliotoxins, produced by fungi like Aspergillus, Candida, and Penicillium, may influence immune function. If chronic mold exposure is suspected, this test can help detect mycotoxin levels.
How to Use the Total Mycotoxin Panel by RealTime Laboratories in Clinic
Here are the instructions for the Total Mycotoxin Panel:
Preparation Before Sample Collection:
- Avoid collecting samples during menstruation.
- No other preparation is needed for the collection.
Urine Sample Collection:
- Collect first-morning urine.
- Use the provided conical cup.
- Transfer urine into a specimen tube, filling it halfway.
- Secure the cap on the tube.
- Label the tube with your name, date of birth, and collection date and time.
- Complete the lab requisition form.
Handling and Sending Samples:
- Place the sample in a biohazard bag.
- Put the bag in the test kit box.
- Freeze the test kit box until shipping.
- Ship the sample within 48 hours.
- Use the prepaid mailer and keep the tracking number.
Results and Follow-Up:
Results typically take 7-14 days after the lab receives the samples, but this timeframe is not guaranteed.
The provider will notify you of the results and schedule a follow-up.
Additional tests may be needed to explore other factors related to symptoms.
Labs to Consider for Further Refinement of Treatments
Here are some other functional labs from RealTime Laboratories to consider:
Total Mycotoxin Panel Follow-Up
Customized plans may be needed based on lab results. These plans can include guidance on reducing exposure through lifestyle changes, nutrition advice, and supplement suggestions. A retest in 3-6 months may be helpful to monitor progress and adjust strategies.
EMMA
EMMA stands for Environmental Mold and Mycotoxin Assessment. The EMMA test evaluates molds and mycotoxins in the environment. It analyzes the 16 mycotoxins of the Total Mycotoxin Panel and includes an assessment of 12 additional molds. This test uses a fungal count Dx test for greater sensitivity. Samples from HVAC filters or suspected mold areas are tested. This test can be combined with the Total Mycotoxin Panel to identify exposure sources.
Candida Panel
Candida is a type of fungus that can affect various body systems. This fungus may cause gastrointestinal, skin, urogenital, or systemic issues. The Candida Panel detects five Candida species that may impact health. It uses PCR technology for sensitivity. If fungal or mold sensitivity is suspected, this test can be considered alongside the Total Mycotoxin Panel.
[signup]
Summary
If someone spends time in environments at risk for mold, such as damp or water-damaged buildings, or has unexplained immune or fatigue issues, a mycotoxin screening may be worth considering. Mycotoxin exposure is often overlooked and should be explored for relevant individuals, as it may contribute to chronic health issues. The Total Mycotoxin Panel can help detect common mycotoxins associated with these concerns. Clinical and environmental history is important in determining appropriate actions. Additional tests, like the EMMA test, may be needed to identify exposure sources. Once these elements are assessed, comprehensive strategies can be developed to manage exposure and support health.